Lumina Specialist Hospital Business Plan › Section 3 › Industry & Market Analysis

South Africa’s private hospital sector is large, sophisticated and
resilient, but highly concentrated and geographically uneven. The
structural features that make it attractive — a wealthy insured pool, a
heavy disease burden and acute specialist scarcity — also define where a
new entrant can credibly compete.

3.1 Market size & growth

The South African hospitals market is forecast to generate
approximately US$8.27 billion of revenue in 2025 and to grow at a
compound annual rate of about 2.25% to roughly US$9.04 billion by 2029.
Within the broader healthcare-provider economy, hospital and specialist
services represent the largest pools of spend. Growth is underpinned by
population expansion, an ageing insured base, the rising prevalence of
chronic disease and continued private-sector capital investment, even as
macroeconomic pressure constrains the rate of medical-scheme membership
growth.

Figure 3.

3.2 A two-tier system

The defining feature of South African healthcare is its two-tier
structure. The public sector serves roughly 80% of the population on
close to half of total health spend, while the private sector serves
about 20% of the population but accounts for approximately half of
expenditure. This concentration of resources in the private sector —
financed predominantly through medical schemes — creates a well-funded,
quality-sensitive market segment that is the natural target for a
specialist hospital.

Figure 4.

3.3 The medical-scheme demand pool

Medical schemes are the primary payers for private hospital care. In
2024, 71 registered schemes (16 open and 55 restricted) covered
approximately 9.17 million beneficiaries — a marginal 0.45% increase on
2023 and a slowly declining share of a growing population. The industry
remained financially sound, with a solvency ratio of 40.87% (well above
the 25% minimum) and a net surplus of R3.13 billion. Two features matter
for Lumina: first, the pool is ageing (average beneficiary age rose to
34.2 years and the pensioner ratio to 9.8%), which raises utilisation of
exactly the specialist services Lumina will offer; second, membership is
heavily concentrated, with Discovery Health (~2.7 million beneficiaries)
and GEMS (~2.3 million) dominating.

Figure 5.

Where scheme money is spent reinforces the specialist-hospital case.
Total benefits paid reached R259.3 billion in 2024, up 8.5% year on
year. Hospitals accounted for 36% of benefits and specialists a further
28% — together almost two-thirds of all scheme spend — with the cost per
hospital admission rising 9.9% even as admission numbers fell, evidence
of rising acuity and case complexity.

Figure 6.

3.4 Specialist scarcity — the core opportunity

The single most important structural driver of the Lumina thesis is
the chronic under-supply of doctors and, acutely, of specialists. South
Africa’s doctor-to-population ratio is about 0.31 per 1,000 — less than
a third of the WHO benchmark of 1 per 1,000. The picture is starker in
sub-specialties: nephrologist density stood at about 2.5 per million
population, against an upper-middle-income benchmark of roughly 5.1 per
million, and renal-replacement-therapy access in the private sector (855
per million) dwarfs that in the public sector (66 per million), a gap
driven by access rather than disease. Several provinces, including
Mpumalanga, have experienced periods with no resident nephrologist at
all, and oncology services in some regions have come under severe
strain.

Figure 7.

Demand is amplified by the disease burden. Non-communicable diseases
account for roughly 55% of national deaths; an estimated 55% of adults
are overweight and 38% physically inactive; and about 15% of the
population is diabetic or pre-diabetic. These conditions feed directly
into the cardiac, renal and oncology caseloads that anchor Lumina’s
service mix. A pool of recently qualified but as-yet-unplaced doctors —
around 1,800 in 2025 — also offers a recruitable talent base for a
well-run private platform.

3.5 Policy context: National Health Insurance

The National Health Insurance (NHI) Act was signed into law in May
2024 but, as at the date of this Plan, no effective date has been
proclaimed and the Act is the subject of multiple legal challenges.
Implementation is phased and widely expected to take a decade or more;
the Minister of Health has indicated that medical schemes are unlikely
to be materially affected for 10–15 years. For a venture with a
seven-year base-case horizon and a Year-7 exit, the near-to-medium-term
operating environment is therefore expected to remain anchored in the
existing medical-scheme funding model. Nonetheless, NHI represents a
genuine long-run policy risk to private tariffs and the role of schemes,
and is treated as such in the risk register.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Lumina Health Holdings (Pty) Ltd.